FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120391347> ?p ?o ?g. }

• W2120391347 endingPage "1915" @default.
• W2120391347 startingPage "1907" @default.
• W2120391347 abstract "Calcium-channel blockers (CCBs) reduce systolic blood pressure and stroke-related mortality in stroke-prone spontaneously hypertensive rats (SPSHR). Brain ischemia is associated with loss of intracellular antioxidants. Increased formation of oxygen radicals and oxidation of LDL may enhance arterial vasoconstriction by various mechanisms. CCBs that also exert antioxidative properties in vitro may therefore be particularly useful. To investigate such antioxidant effects in vivo, we determined several parameters of LDL oxidation in SPSHR treated with two 1,4-dihydropyridine-type (1,4-DHP) CCBs of different lipophilic properties and compared them with antioxidant-treated and untreated controls. We also tested whether these drugs decrease the formation of oxidation-specific epitopes in arteries.Five groups of 9 to 14 SPSHR each (aged 8 weeks) were treated with 80 mg/kg body wt per day nifedipine, 1 mg or 0.3 mg/kg body wt per day lacidipine, vitamin E (100 IU/d), or carrier for 5 weeks. A group of Wistar-Kyoto rats was used as normotensive control. Plasma samples were taken, and LDL was isolated by ultracentrifugation. Then LDL was exposed to oxygen radicals generated by xanthine/xanthine oxidase reaction (2 mmol/L xanthine+100 mU/mL xanthine oxidase), and several parameters of oxidation were determined. The presence of native apolipoprotein B and oxidation-specific epitopes in the carotid and middle cerebral arteries was determined immunocytochemically.1,4-DHP CCBs completely prevented mortality. Normotensive Wistar-Kyoto rats showed less oxidation than control SPSHR. Plasma lipoperoxide levels were 0.87+/-0.27 micromol/L in control SPSHR, 0.69+/-0.19 and 0.63+/-0.20 micromol/L in the groups treated with 0.3 and 1 mg lacidipine, respectively, and 0.68+/-0.23 micromol/L in nifedipine-treated animals (P<0.05 versus control SPSHR for all values). Both CCBs significantly decreased formation of conjugated dienes and prolonged the lag time in LDL exposed to oxygen radicals. Similarly, lipoperoxides and malondialdehyde were significantly reduced (P<0.05). Reduced relative electrophoretic mobility and increased trinitrobenzenesulfonic acid reactivity of LDL from treated rats (P<0.01) also indicated that fewer lysine residues of apolipoprotein B were oxidatively modified in the presence of 1,4-DHP CCBs. Finally, these drugs reduced the intimal presence of apolipoprotein B and oxidized LDL (oxidation-specific epitopes) in carotid and middle cerebral arteries.In the SPSHR model, 1,4-DHP CCBs reduce plasma and LDL oxidation and formation of oxidation-specific epitopes and prolong survival independently of blood pressure modifications. Our results support the concept that the in vivo protective effect of these drugs on cerebral ischemia and stroke may in part result from inhibition of oxidative processes." @default.
• W2120391347 created "2016-06-24" @default.
• W2120391347 creator A5007365295 @default.
• W2120391347 creator A5020230136 @default.
• W2120391347 creator A5027445006 @default.
• W2120391347 creator A5034467556 @default.
• W2120391347 creator A5036082512 @default.
• W2120391347 creator A5049658448 @default.
• W2120391347 creator A5058269414 @default.
• W2120391347 creator A5060562909 @default.
• W2120391347 creator A5061269136 @default.
• W2120391347 creator A5068055181 @default.
• W2120391347 creator A5071475767 @default.
• W2120391347 creator A5076558291 @default.
• W2120391347 creator A5084649251 @default.
• W2120391347 date "1999-09-01" @default.
• W2120391347 modified "2023-10-17" @default.
• W2120391347 title "1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats" @default.
• W2120391347 cites W1492227883 @default.
• W2120391347 cites W1775749144 @default.
• W2120391347 cites W1965281006 @default.
• W2120391347 cites W1967535634 @default.
• W2120391347 cites W1974149808 @default.
• W2120391347 cites W1975082325 @default.
• W2120391347 cites W1975141925 @default.
• W2120391347 cites W1986498390 @default.
• W2120391347 cites W1991726504 @default.
• W2120391347 cites W1992026104 @default.
• W2120391347 cites W1994244815 @default.
• W2120391347 cites W2003888405 @default.
• W2120391347 cites W2017916005 @default.
• W2120391347 cites W2020227605 @default.
• W2120391347 cites W2020438152 @default.
• W2120391347 cites W2023791252 @default.
• W2120391347 cites W2029994534 @default.
• W2120391347 cites W2036717077 @default.
• W2120391347 cites W2042794182 @default.
• W2120391347 cites W2048225623 @default.
• W2120391347 cites W2051623738 @default.
• W2120391347 cites W2057809540 @default.
• W2120391347 cites W2059686465 @default.
• W2120391347 cites W2071024403 @default.
• W2120391347 cites W2071089590 @default.
• W2120391347 cites W2080013238 @default.
• W2120391347 cites W2081203751 @default.
• W2120391347 cites W2081748503 @default.
• W2120391347 cites W2088799496 @default.
• W2120391347 cites W2089431073 @default.
• W2120391347 cites W2089988280 @default.
• W2120391347 cites W2092625339 @default.
• W2120391347 cites W2095282566 @default.
• W2120391347 cites W2114631850 @default.
• W2120391347 cites W2127775221 @default.
• W2120391347 cites W2139293212 @default.
• W2120391347 cites W2205040467 @default.
• W2120391347 cites W2330978839 @default.
• W2120391347 cites W2335380277 @default.
• W2120391347 cites W2401714807 @default.
• W2120391347 doi "https://doi.org/10.1161/01.str.30.9.1907" @default.
• W2120391347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10471444" @default.
• W2120391347 hasPublicationYear "1999" @default.
• W2120391347 type Work @default.
• W2120391347 sameAs 2120391347 @default.
• W2120391347 citedByCount "51" @default.
• W2120391347 countsByYear W21203913472012 @default.
• W2120391347 countsByYear W21203913472013 @default.
• W2120391347 countsByYear W21203913472014 @default.
• W2120391347 countsByYear W21203913472015 @default.
• W2120391347 countsByYear W21203913472016 @default.
• W2120391347 countsByYear W21203913472017 @default.
• W2120391347 countsByYear W21203913472020 @default.
• W2120391347 countsByYear W21203913472021 @default.
• W2120391347 countsByYear W21203913472022 @default.
• W2120391347 crossrefType "journal-article" @default.
• W2120391347 hasAuthorship W2120391347A5007365295 @default.
• W2120391347 hasAuthorship W2120391347A5020230136 @default.
• W2120391347 hasAuthorship W2120391347A5027445006 @default.
• W2120391347 hasAuthorship W2120391347A5034467556 @default.
• W2120391347 hasAuthorship W2120391347A5036082512 @default.
• W2120391347 hasAuthorship W2120391347A5049658448 @default.
• W2120391347 hasAuthorship W2120391347A5058269414 @default.
• W2120391347 hasAuthorship W2120391347A5060562909 @default.
• W2120391347 hasAuthorship W2120391347A5061269136 @default.
• W2120391347 hasAuthorship W2120391347A5068055181 @default.
• W2120391347 hasAuthorship W2120391347A5071475767 @default.
• W2120391347 hasAuthorship W2120391347A5076558291 @default.
• W2120391347 hasAuthorship W2120391347A5084649251 @default.
• W2120391347 hasBestOaLocation W21203913471 @default.
• W2120391347 hasConcept C126322002 @default.
• W2120391347 hasConcept C134018914 @default.
• W2120391347 hasConcept C170493617 @default.
• W2120391347 hasConcept C181199279 @default.
• W2120391347 hasConcept C185592680 @default.
• W2120391347 hasConcept C2776885963 @default.
• W2120391347 hasConcept C2777294900 @default.
• W2120391347 hasConcept C2778004101 @default.
• W2120391347 hasConcept C2778102346 @default.
• W2120391347 hasConcept C2779066535 @default.

• next